For patients with obesity, GLP-1 RAs have emerged as a noninvasive alternative to bariatric surgery, offering compelling weight loss with similar effects in glycemic control [36]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.